| |
Latest 10 SEC filings (by transaction date) for NWBO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 1/23 | Nov 17/23 | Malik Navid | Direct Ownership | Common Stock | S - Open market or private sale | 295,000 | $0.819 |
Dec 1/23 | Nov 17/23 | Malik Navid | Direct Ownership | Common Stock | S - Open market or private sale | 150,000 | $0.823 |
Dec 1/23 | Nov 16/23 | Malik Navid | Direct Ownership | Common Stock | S - Open market or private sale | 125,000 | $0.835 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for NWBO within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 1/23 | Nov 17/23 | Malik Navid | Direct Ownership | Common Stock | S - Open market or private sale | 295,000 | $0.819 |
Dec 1/23 | Nov 17/23 | Malik Navid | Direct Ownership | Common Stock | S - Open market or private sale | 150,000 | $0.823 |
Dec 1/23 | Nov 16/23 | Malik Navid | Direct Ownership | Common Stock | S - Open market or private sale | 125,000 | $0.835 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |